[ARWR] QoQ Quarter Result on 31-Mar-2023 [#Q2]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
02-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q2]
Profit Trend
QoQ- 216.42%
YoY- 9.71%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 3,551 16,097 15,825 146,267 62,546 31,575 32,412 -77.01%
PBT -138,689 -108,990 -103,383 47,676 -41,794 -82,157 -72,046 54.56%
Tax -3,313 2,025 742 -999 17 3,785 -863 144.57%
NP -132,864 -109,679 -102,946 48,675 -41,811 -85,942 -71,183 51.42%
Tax Rate - - - 2.10% - - - -
Total Cost 136,415 125,776 118,771 97,592 104,357 117,517 103,595 20.07%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -3,741.59 -681.36 -650.53 33.28 -66.85 -272.18 -219.62 558.68%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -1.24 -1.02 -0.96 0.46 -0.39 -0.81 -0.67 50.57%
EPS Diluted -1.24 -1.02 -0.96 0.45 -0.39 -0.81 -0.67 50.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.